5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
NEUTRAL | NEUTRAL | NEUTRAL | BUY | SELL |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 3.07▼ | 3.07▼ | 3.06▼ | 2.98▲ | 3.00▲ |
MA10 | 3.06▼ | 3.06▼ | 3.02▲ | 2.91▲ | 3.04▲ |
MA20 | 2.98▲ | 2.97▲ | 2.98▲ | 2.97▲ | 3.05▼ |
MA50 | 3.02▲ | 3.03▲ | 3.06▼ | 3.10▼ | 3.34▼ |
MA100 | 3.10▼ | 3.11▼ | 3.13▼ | 3.10▼ | 2.27▲ |
MA200 | 3.19▼ | 3.14▼ | 3.16▼ | 3.31▼ | N/A |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | 0.009▲ | 0.012▲ | 0.015▲ | 0.016▲ | -0.006▼ |
RSI | 52.031▲ | 51.705▲ | 51.753▲ | 52.376▲ | 48.009▼ |
STOCH | 73.769 | 74.367 | 78.256 | 58.454 | 20.097 |
WILL %R | -30.000 | -30.000 | -26.471 | -25.852 | -73.377 |
CCI | 15.286 | 29.520 | 53.385 | 78.623 | -17.180 |
Thursday, May 08, 2025 09:00 PM
Encinitas, California-- (Newsfile Corp. - May 9, 2025) - Kiora Pharmaceuticals, Inc. (NASDAQ: KPRX) ("Kiora" or the "Company") today announced first quarter 2025 financial results and provided an ...
|
Thursday, May 01, 2025 05:00 PM
Kiora Pharmaceuticals (NASDAQ:KPRX – Get Free Report) is expected to issue its Q1 2025 quarterly earnings data before the market opens on Friday, May 9th. Analysts expect the company to announce ...
|
Tuesday, March 25, 2025 04:30 AM
KIORA PHARMACEUTICALS ($KPRX) posted quarterly earnings results on Tuesday, March 25th. The company reported earnings of -$1.04 per share, missing estimates of -$0.56 ...
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
14/07/25 | 3.05 | 3.05 | 3.05 | 3.05 | 4,129 |
11/07/25 | 3.03 | 3.179 | 2.91 | 3.00 | 79,400 |
10/07/25 | 2.95 | 3.10 | 2.93 | 3.01 | 146,100 |
09/07/25 | 2.82 | 3.10 | 2.80 | 2.97 | 151,100 |
08/07/25 | 2.80 | 2.89 | 2.80 | 2.86 | 21,600 |
07/07/25 | 2.83 | 2.90 | 2.80 | 2.81 | 23,100 |
03/07/25 | 2.81 | 2.96 | 2.81 | 2.85 | 14,400 |
02/07/25 | 2.80 | 2.94 | 2.80 | 2.86 | 15,800 |
01/07/25 | 2.83 | 2.87 | 2.68 | 2.82 | 15,700 |
30/06/25 | 2.95 | 2.99 | 2.69 | 2.88 | 70,600 |
|
|
||||
|
|
||||
|
|